PillRx only · Capsule, Delayed Release · Oral
Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease
Brands: Pancreaze · Pancrelipase Amylase + Pancrelipase Lipase + Pancrelipase Protease
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US6 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers1 labelers
Packages6
DEA / ScheduleNone
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| VIVUS LLC | unknown | 6 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 23, 2023RECALLRecall (Class III): PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Camp…
Failed Stability Specifications — Recalling firm: Vivus, Inc. — Nationwide within the United States